Pacific Biosciences of California (PACB) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.15 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +29.41%. A quarter ago, it was expected that this maker of genetic analysis technology would post a loss of $0.19 per share when it actually produced a loss of $0.12, delivering a surprise of +36.84%. ...